Ten-Year Outcomes of Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease: The BEST Extended 10 Y Follow-up
Latest Information Update: 07 Aug 2022
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Acronyms BEST Extended; The BEST Extended 10 Y Follow-up
- 11 Jul 2022 Status changed from active, no longer recruiting to completed.
- 30 Jun 2022 Status changed from not yet recruiting to active, no longer recruiting.
- 30 Jun 2022 Planned End Date changed from 30 Oct 2022 to 30 Aug 2022.